Skip to main content
. 2018 Nov 7;8:16475. doi: 10.1038/s41598-018-34830-9

Figure 3.

Figure 3

Effects of intra-articular administration of BMS-345541 in early phase of OA. (a) Safranin O staining and immunohistochemistry of NF-κB-related proteins and catabolic enzymes in the BMS-345541-treated cartilage at 2 weeks after surgical induction of OA. Inset boxes in safranin O staining indicate enlarged images. Scale bar, 50 µm. (b) The percentage of positive cells in the immunohistochemistry. *P < 0.05 vs vehicle by the Kruskal-Wallis test & Dunn’s post hoc test for unequal variance, n = 4 mice per group.